F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: A prospective pilot study
Autor: | Soujanya Ratna Edupuganti, Philippe Goupille, David Ternant, Denis Mulleman, Gilles Paintaud, François Tranquart, Maxime Courtehoux, Véronique Eder |
---|---|
Rok vydání: | 2014 |
Předmět: |
Adult
Male medicine.medical_specialty Time Factors Pilot Projects Fluorodeoxyglucose positron emission tomography Arthritis Rheumatoid Rheumatology Fluorodeoxyglucose F18 medicine Adalimumab Humans Prospective Studies Prospective cohort study Tumor necrosis factor α Aged medicine.diagnostic_test business.industry Tumor Necrosis Factor-alpha Antagonist Middle Aged medicine.disease Positron emission tomography Rheumatoid arthritis Antirheumatic Agents Positron-Emission Tomography Tumor necrosis factor alpha Female Radiology Radiopharmaceuticals business Nuclear medicine medicine.drug Follow-Up Studies |
Zdroj: | Joint bone spine. 82(5) |
ISSN: | 1778-7254 |
Popis: | Joint Bone Spine - In Press.Proof corrected by the author Available online since samedi 14 mars 2015 |
Databáze: | OpenAIRE |
Externí odkaz: |
Pro tento záznam nejsou dostupné žádné jednotky.